
The European Union ramped up its legal campaign against the UK over breaches to the Brexit deal, days after legislation allowing Britain to scrap parts of the Northern Ireland protocol cleared the House of Commons.
On Friday, the European Commission launched four additional infringement proceedings against the UK, claiming the government had failed to comply with customs and value-added tax rules it signed up to.
Britain has two months to respond, after which the European Commission said it is ready to take further measures.
It brings to seven the number of “infringement procedures” the European Commission has launched over what it sees as Britain’s failure to respect Northern Ireland trade aspects of the Brexit divorce deal agreed by both sides.
The procedures could result in the European Court of Justice (ECJ) imposing fines, although this would likely not happen for at least a year. The Commission said it stood ready to launch further procedures to protect the EU single market from British violations of the protocol.
Britain said the EU action was “disappointing”. “A legal dispute is in nobody’s interest and will not fix the problems facing the people and businesses of Northern Ireland. The EU is left no worse off as a result of the proposals we have made in the Northern Ireland Protocol Bill,” a government spokesperson said.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Live Nation Under Criminal Antitrust Investigation Over Pandemic-Era Refund Policies
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas